John Cochran
Neurology · Alexandria, VANPI 1811989957
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,845 of the $53,750 with a category attached, or 79.7%. Amgen accounts for 76.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $39,926 and has fallen 99.4% since, to $252 in 2022. Among neurology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $310.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$41K
- Eisai Inc.$10K
- UCB, Inc.$540
- Supernus Pharmaceuticals, Inc.$416
- Avanir Pharmaceuticals, Inc.$270
- Novartis$240
- plus $2K from 21 others
Across 7 payments — averaging $3551.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$25K
What the payments were for
- Speaking & faculty fees$42,84580%
- Travel & lodging$6,84013%
- Food & beverage$4,0538%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 45 | $40,978 |
| Eisai Inc. | 12 | $9,540 |
| UCB, Inc. | 9 | $540 |
| Supernus Pharmaceuticals, Inc. | 18 | $416 |
| Avanir Pharmaceuticals, Inc. | 9 | $270 |
| Novartis | 15 | $240 |
| Lilly USA, LLC | 4 | $231 |
| Sunovion Pharmaceuticals Inc. | 7 | $200 |
| Sanofi | 8 | $186 |
| Jazz Pharmaceuticals Inc. | 5 | $176 |
| AstraZeneca | 5 | $156 |
| AbbVie | 8 | $152 |
| Biogen | 5 | $115 |
| Ceribell, Inc. | 1 | $106 |
| Teva Pharmaceuticals USA, Inc. | 2 | $60 |
| EMD Serono, Inc. | 3 | $57 |
| Acorda Therapeutics, Inc | 3 | $55 |
| Upsher-smith Laboratories LLC | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Amneal Pharmaceuticals LLC | 3 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Harmony Biosciences LLC | 1 | $21 |
| Fisher & Paykel Healthcare Inc | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$53,750 in reported general payments places this provider in the 90th percentile of 474 neurology providers in Virginia.
Other neurology in Alexandria
- Ramsey FalconerAlexandria$2M
- Simon FishmanAlexandria$207K
- Mohankumar KurukumbiAlexandria$64K
- Eric SklarAlexandria$52K
- Sean RogersAlexandria$28K
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
- Jill CramerChristiansburg$598K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.